Demographic, Clinical Profile of Rheumatoid Arthritis Patients and Their Association with Disease Severity in Ghana

Buckman, Tonnies Abeku; Sakyi, Samuel Asamoah; Yeboah-Mensah, Kwame; Antwi, Maxwell Hubert; Darban, Isaac; Owusu-Brenya, Lawrence; Yorke, Joseph; Boateng, Andy Opoku; Senu, Ebenezer; Dompreh, Albert; Addei, Akwasi Minnah; Boateng, Richard; Yankey, Ortis; Tandoh, Samuel

doi:https://doi.org/10.1155/2024/6639079

International Journal of Rheumatology

On this page

Abstract Introduction Results Discussion Conclusion Data Availability Ethical Approval Consent Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2024 | Article ID 6639079 | https://doi.org/10.1155/2024/6639079

Demographic, Clinical Profile of Rheumatoid Arthritis Patients and Their Association with Disease Severity in Ghana

Tonnies Abeku Buckman,^1,2Samuel Asamoah Sakyi,²Kwame Yeboah-Mensah,³Maxwell Hubert Antwi,⁴Isaac Darban,⁴Lawrence Owusu-Brenya,²Joseph Yorke,⁵Andy Opoku Boateng,²Ebenezer Senu,²Albert Dompreh,⁶Akwasi Minnah Addei,⁷and Richard Boateng⁶ et al.

Academic Editor: Rishi Pal

Received26 Apr 2023

Revised10 Nov 2023

Accepted21 Dec 2023

Published12 Jan 2024

Abstract

Background. Rheumatoid arthritis (RA) is one of the frequent chronic, systemic, inflammatory autoimmune disorders with an estimated global prevalence of 1%. RA leads to joint destruction and disability if left untreated. Ghana has seen very few studies on RA, and little is known about the disease’s severity and related variables. This study sought to characterize the clinical presentation and determine disease severity and associated risk factors with disease severity among RA patients in a tertiary hospital in Ghana. Methods. This cross-sectional study was conducted between September 2020 and August 2021. This study included 56 consecutively consenting RA patients from the Komfo Anokye Teaching Hospital orthopaedic unit. Diagnosis of RA was based on the updated American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) 2022 rheumatoid arthritis classification criteria by a rheumatologist. A study questionnaire was used to gather participant demographics and clinical features, and results from the laboratory were taken from the patients’ charts and medical records. The patients’ disease severity was evaluated based on the rheumatoid arthritis disease activity score, which is based on a 28-joint count (DAS28), and their functioning was evaluated using the modified health assessment questionnaire. Results. The participants’ mean age was years. Out of the total participants, 46 were females, and 10 were males (female-to-male ratio 4.6 : 1). Moreover, 37.50% had arthritis of the hand; 5.30% had severe disease, and 94.60% were not severe. A majority (76.80%) were on methotrexate medication. The most frequently involved joints were the knee (42.90%), wrist (32.10%), and elbow (12.50%). There was no statistically significant association with disease severity and a functional status score of >0.5 (cOR: 10.60, 95% CI (0.52-217.30); ). In addition, marital status (), disease duration (), family complaints (), and ESR () were significantly associated with disease severity. Conclusion. RA is predominant among elder populations and females. Disease duration, family complaints, and ESR are associated with disease severity. The findings of this study call for interventions towards ensuring early diagnosis of RA among high-risk populations to enhance good management practices.

1. Introduction

Rheumatoid arthritis is an autoimmune disease associated with chronic inflammation that progressively causes extensive damage to the joints of the body [1]. Studies have demonstrated that extra-articular presentations such as extensive bone and cartilage degradation and systemic manifestations seen among RA patients are associated with the severity of RA [2]. Anticyclic protein antibodies, rheumatoid nodules, and rheumatoid factor are among the other clinical manifestations that have been linked to the severity of RA in Caucasians and Asians [2, 3]. Poor prognosis factors for RA include persistently moderate or high disease activity (after csDMARD therapy) based on composite measures such as joint counts despite csDMARD therapy, high levels of acute phase reactants, high counts of swollen joints, presence of RF and/or ACPA, especially at high levels, early erosions, and failure of two or more csDMARDs. [4]. However, in Africa, delayed RA diagnosis is a key contributor to severe RA since most potential RA patients fail to report to hospitals for early diagnosis and treatment as many associate RA with superstitions [5, 6]. Although few studies have demonstrated low to mild RA in Africa, current studies have demonstrated the severity of RA in some parts of Africa [7]. Additionally, these reports of the severity of RA in some parts of Africa have been associated with some clinical presentations [6]. Studies have shown that most clinical presentations maybe influenced by genetic and lifestyle factors and, hence, may be population specific [8, 9]. Furthermore, investigating the clinical presentation of RA patients is necessary to initiate early and appropriate treatment guidelines and alleviate or prevent severe RA. Although the clinical presentation of RA has been associated with severe RA in other populations, no studies have investigated the clinical presentations of RA and their association with severe RA in Ghana. Thus, the purpose of this study is to examine the medical profile of RA and its relationship to RA severity in the Ghanaian population.

2. Method

2.1. Study Design and Setting

A cross-sectional study was conducted between September 2020 and August 2021.

Patient recruitment was done at the rheumatology units of Komfo Anokye Teaching Hospital (KATH) and Kumasi, Ghana. KATH, the second largest hospital in Ghana, is a 1200-bed facility in the Kumasi Metropolis. Kumasi is the second major city in Ghana and has a projected population of 4,780,380. The Rheumatology unit provides healthcare services to both in and outpatients with rheumatologic and autoimmune conditions.

2.2. Study Population

Patients who visited the clinic for rheumatology between September 2020 and August 2021 were qualified for participation. Patients included in this study (1) were diagnosed with RA by using the 2010 ACR/EULAR classification key [10], (2) were 18 years of age and above, and (3) gave their informed consent to be part of this study [11]. Any patient with undifferentiated arthritis or mixed connective tissue ailment was excluded.

2.3. Data Collection

Questionnaires were administered to obtain sociodemographic data from the participants.

Marital status, educational attainment, work position, age, sex, and history of alcohol and tobacco use are among the data gathered. Clinical information on the most common symptoms of RA, such as joint ache and swelling, stiffness in the morning, hyperthermia and weight depreciation, back pain, extra-articular manifestation, length of time since diagnosis, medication currently taken, family history, and existence of other chronic illnesses, were gathered and obtained from the hospital’s archives. Weight was measured in the upright position to the nearest 0.1 kg using a calibrated balance beam scale. Height was measured (subjects stood erect, barefoot, with feet together, and looking forward) to the nearest 0.1 m using a measuring tape. Body mass index (BMI) was calculated using the equation . A was deemed underweight, 18.5–24.9 kg/m² was regarded normal, and 25–29.9 kg/m² was considered overweight [1]. Blood pressure was measured with an automated blood pressure apparatus (Omron MX3-Omron Matsusaka Co., Ltd., Japan) from the right arm after the subject had been made to sit for at least five minutes. The average of the two readings taken five minutes apart was recorded.

In this study, laboratory data for ESR levels, haemoglobin count, C-reactive protein (CRP), and rheumatoid factor (RF) were gathered. Positive or unfavourable qualitative reports were made on RF. The immunoassay analyzer (AQT90) was used to quantify CRP. The results were classified as elevated or normal, with <3 mg/L representing normal values for whole blood. If an individual’s ESR was greater than 30 mm/h for females and more than 20 mm/h for males, it was deemed elevated for those over 50. The elevated ESR threshold for individuals aged 50 years or older was defined as >20 mm/h for females and >15 mm/h for males [12].

The World Health Organisation (WHO) criteria were followed in the classification of haemoglobin levels, which were classified as mild anaemia (11.0–13.0 g/dL for males and 11.0–12 g/dL for females), moderate anaemia (8.0–11.0 g/dL for both sexes), or severe anaemia (<8.0 g/dL for both sexes) [12]. Utilising the modified health assessment questionnaire (MHAQ), patients’ performance disabilities were evaluated. The range of the MHAQ overall score is 0.0 to 3.0. Mild (), moderate (), and severe () are the three categories for the MHAQ scores. The average score of participants was calculated, and this allowed for the classification of each participant’s score as either high or low. The MHAQ total score ranges from 0.0 to 3.0. The MHAQ scores are categorised as mild (), moderate (), and severe (). The questionnaire asks about how easy their daily activities are, as well as a disability assessment exercise and questions about observed patient satisfaction with routine daily living activities [13]. Each participant’s score was categorised as either high or low based on the frequencies of their scores, with an average score of 0.5 being utilised. In addition to questions about observed patient satisfaction with routine activities of daily life and a reported change in difficulty, the questionnaire asks participants how easily they completed everyday tasks, which is an assessment of their impairment. BRAF-NRS were used for fatigue assessment [13], with individuals who had a mean value of 5 or above were deemed to be fatigued. The rheumatoid arthritis disease activity score, which has been approved for classifying diseases, was used to assess the intensity of the RA. The formula for calculating the DAS28 is “”. DAS28 (<3.2) means low disease activity, but ≤5.1 indicates moderate disease activity while a high disease activity score is >5.1 indicating a severe ailment [14].

2.4. Data Analysis

The data were exported from Excel version 16 into SPSS version 16.0. Means and standard deviations were used to summarise continuous data with a normally distributed distribution, and medians and interquartile ranges (IQRs) were used for data that were not normally distributed. As a result of the collection of qualitative data, categorical statistics were summarised as frequencies and percentages. The sociodemographic variables, clinical features, and laboratory features were among the exploratory variables. Every factor from the bivariate analysis was taken into account in the multivariable analysis model. Though having a value > 0.05, confounding variables like literacy rate and BMI were kept in the last model.

3. Results

In all, 56 participants diagnosed with RA were enrolled in the study. The participants’ average age was years, where about 25.0% were older than 60 years, 30.4% were in the 51-60 years age group, 19.6% each were in the 41-50 years age group and 30-40 years age group, and 5.4% were within less than 30 years old. Females were 82.1%, and males made up the remaining 17.9%. Also, 64.3% were married, and 35.7% of them were single. About 58.9% were informally employed, while 16.1%, 14.3%, and 10.7% were formally employed, unemployed, and retired, respectively. The ethnicity of participants was as follows: Akan’s formed 58.9% of the participants, while 16.1%, 14.3%, 7.1%, and 3.6% were Ewe, Ga, Northerner, and Krobo, respectively. Those who had not received formal education were 25.0%, while 51.8% had received primary education, 19.6% had received secondary education, and only 3.6% had received tertiary level of education. Christians were 96.4%, and Muslims formed the remaining 3.6%. Those who exercise frequently were 25.0%, while the 75.0% did not exercise or have irregular exercise. Moreover, only 1.8% were smokers, 5.4% had sickle cell disease, and 7.1% had history of cardiovascular disease (Table 1).

Nearly 19.6% experienced extra-articular manifestation (EAM), and 21.4% had deformed joints. Moreover, 12.5% had difficulty in breathing, and 19.6% had morning stiffness. Of the 56 participants, 26.8% had arthritis of more than 3 or more joints with 26.5% having general malaise as a symptom. As part of the symptoms recorded, 16.1%, 17.9%, 39.3%, 32.1%, and 32.1% had weight loss, fever of unknown origin, minimized feeling of back pain, neck pain, and severe back pains, respectively. Also, 23.2% had stiff spine, and 37.5% had arthritis of the hand (Table 2).

Higher portions of the participants, 76.8% and 57.1%, were taking methotrexate and folic acid, respectively, and few of the participants, 19.6%, 14.3%, 12.5%, and 39.3%, were on nifedipine, amlodipine, losartan, and prednisolone drugs, respectively (Table 3).

Many patients involved in the study were obese (46.4%) with few being underweight (3.6%). Moreover, 39.3% and 19.6% had normal systolic and diastolic pressure, respectively; 32.1% and 39.3% were in the prehypertensive stage for systolic and diastolic pressure, respectively. Also, 28.6% and 39.3% were in stage 1 hypertensive group for systolic and diastolic pressure, respectively. There was no participant for stage 2 hypertension for systolic pressure, but 1.8% were in stage 2 hypertension category for diastolic blood pressure. ESR level was elevated in 69.6% of the participants with the median ESR of 36.0 mm/hour. Fairly, many of the participants (55.4%) had mild anaemia, and 64.3% were positive for RF. From the total participants, 39 had their C-reactive protein measured, and 30.4% had elevated levels. The mean waist circumference was , and the mean hip circumference measured was (Table 4).

Table 5 summarises the disease duration and the functional disability of the participants. Many participants (85.7%) had the disease for more than 15 months, and 3.6% had experienced previous diagnosis of the condition. With MHAQ levels, 58.9% were having normal, and 7.1% were having severe levels. In addition, 8.9% had family complaints (Table 5).

A greater number (74%) of study participants showed symptoms of pain, and a greater proportion (80%) had swollen joints (Figure 1).

(a)

(b)

A greater number (67.9%) of study participants had low disease activity, 26.9% had moderate disease activity, and 5.4% showed high disease activity using DAS28 (Figure 2).

The knee (42.9%), wrist (32.1%), and elbow (12.5%) were the most involved joint in the study population (Figure 3).

The joints swollen and with pain were accessed from among the participants. 41 were having pains at some joints, and 45 experienced swelling at the joints. Among 41 participants who were in pain, the majority (39.0%) complained of knee aches, a few (2.4%) had pains at the metacarpophalangeal (MCP) joint, and the same proportion had pain at both their MCP and proximal interphalangeal (PIP) joint. From a total of 45 participants who experienced swelling at their joints, 37.8% had swollen wrists, a few (2.2%) had PIP involved, and the same proportion had PIP and MCP swollen (Table 6).

A significant correlation was found between disease severity and marital status (), disease duration (), and family history of RA (). No significant correlation was found between the remaining variables and the intensity of the condition (Table 7).

Characteristics such as hip circumference, waist circumference, age of participants, BMI, Hb, and CRP were not significantly correlated with disease severity (). A significant association was found between disease severity and ESR () and family complaints (). For every mm/hour increase in the ESR of participants, there is a significant 7.7% increase in disease severity. Also, as compared to patients with no family complaints, patients with family complaints have 33 times the chance of having increased disease severity (Table 8).

4. Discussion

Rheumatoid arthritis is still a global health concern as it causes joint damage as well as long-term disability. The goal of the study was to assess the clinical presentation, measure the severity of the disease, and identify the risk factors for severe rheumatoid arthritis (RA) in patients attending a tertiary hospital in Ghana. Clinical, lifestyle, and sociodemographic characteristics were assessed. The study did not see any major significant observations of these characteristics on the disease condition except that rheumatoid arthritis was less recorded among the younger age group as compared to the older age group in this study with a mean age of 51.25. This study is in support of studies that have linked rheumatoid arthritis to age [15, 16].

The clinical diagnostic symptoms that define RA in the study were extra-articular manifestation, deformed joint, difficulty in breathing, stiffness in the morning, arthritis of 3 or more joints, and general malaise which included fever, back pains, sniff spine, and neck pain. Among these symptoms, arthritis of the hand was seen to be the prevailing symptom among the participants even though it was insignificant in correlating to severity. Ochola et al. [6], in their studies, reported that the hand joints were frequently affected by the illness, which is consistent with our findings that hand arthritis was a prevalent symptom. A very low percentage of research participants—nearly 5%—were classified as having an intense disease, which suggests either early disease identification or a good prognosis (disease remission). Significant characteristics that saw a correlation with disease intensity were marital status (), how long a participant has had the disease (), family complaints (), and DAS28 score (). Unfortunately, the remaining laboratory and clinical features that were assessed in the study were not significantly correlated with disease intensity. Marital status has generally been associated with RA health status and again linked with the level of adjustment in the marriage being more important to consider than simply whether or not one is married. Analytical findings from a study that compared three groups assessed on marital status and level of marital adjustment reported that nondistressed married participants tended to have better health than both distressed married and unmarried participants. This study was limited to only marital status and did not go further to know the degree of challenges in the marriage. It is presumed that family pressure with persistent complaints worsens disease severity as compared to nondistressed marriage participants who get the needed support to be both psychologically and mentally sound which mostly promotes disease remission [17, 18]. Also, as compared to patients with no family complaints, patients with family complaints have 33 times the chance of having increased disease severity.

Even though the DAS28 score was recorded mostly among the nonsevere RA patients, it was seen to be significant in the intensity of the disease condition as a high DAS28 score was equally assessed on some severe RA patients. A study done by Ochola et al. [6] reported that a substantial correlation was found between the DAS28 score and the intensity of the RA in the current study, as well as in theirs, with over half of the patients involved in the study having severe RA when the DAS28-ESR score was used. Singwe-Ngandeu et al. [19] have also reported a high DAS28-ESR among most of their studied participants which again saw no major difference with the present study in significance to the disease severity. Findings by Lee et al. [15] found that while individuals in DAS28 remission may still have increased pain and disease progression in cases of sleep disturbances, exhaustion, and incapacity, heightened pain severity was not associated with joint deterioration. Again, only 1 (1.9%) of the patients involved was a smoker, and the association between smoking and RA was not significant. This finding contradicts the studies of Seror et al. [20] where active smoking was significantly correlated with an elevated risk of RA. In the studies conducted by Chang et al. [8] and also by Ishikawa and Terao [21], smoking was found to be linked with an elevated risk of RA, and smoking can also affect the drugs in RA treatment. The difference between our findings and theirs could be linked to the fewer number of our participants who were smokers.

RA disease severity was an independent risk factor for hypertension, anaemia, body mass index, inflammation, and cardiovascular disease in the study since there were no significant associations between RA severity and these clinical characteristics. Masuda et al. [22] reported that the disease duration of RA is a separate risk factor for cardiovascular diseases which was not too different from what the present study observed. Significant unidirectional alterations in receptor expression in RA did not correlate with longer disease duration as reported by Alshevskaya et al. [23] which contradicts our finding where severity was linked to the time frame of the disease condition. Although the trend was very weak [24], findings also indicated that disease intensity had a very slow downward trend over three years in their studies, and they ascribed the duration of care and participants being men as significant related factors with decreased severity of the ailment.

Assessments were conducted on the clinical features of RA based on joint involvement. Although the tiny joints of the wrist and knee were not statistically significant in terms of the disease’s intensity, most patients involved in this study reported joint discomfort and swelling. Zhao et al. [25], in their studies, also reported wrist and ankle joint involvement in RA which was not too different from this current study. Another study by Kanazawa et al. [26] also corroborated our findings in their reports with the wrist joint being again the most affected joint involvement in RA patients. Wrist joint involvement has also been reported by Skakic V. and Skakic C. [27] to be the main predominant joint involvement in RA patients which again was in accordance with our study findings.

Features like participants’ age, circumferences of the waist and hip, and haemoglobin levels were not linked to the intensity of the condition. C-reactive protein as a clinical inflammatory marker in this study for the disease progression was not also seen as a significant characteristic which was supported by similar findings from Fleischmann et al. [28]. The association between disease severity and ESR () was statistically significant. For every mm/hour increase in the ESR of participants, a significant 7.7% increase in disease severity exists according to the present study findings. This finding is in support of a study that has correlated the disease severity to ESR increase [29]. ESR has also been reported to increase RA severity and progression [30].

The limitations of this study are the small sample sizes for part of the study variables; higher sample sizes may be required in future research to accentuate these findings. Additionally, only at the initial contact was the disease intensity assessed necessitating further prospective research to identify additional relevant factors.

5. Conclusion

RA is predominant among elderly populations and females. Knee and wrist joint involvement are the predominant joint involvement in the RA subjects. Disease duration, family complaints, and ESR are linked with disease severity. This study’s findings call for interventions towards prevention or early diagnosis of RA among high-risk populations to enhance good management.

Data Availability

The raw data used to support the findings of this study are available from the corresponding author upon request.

Ethical Approval

This study was conducted under the principles of the Declaration of Helsinki and Good Clinical Practice guidelines. The study was accepted by the Institutional Review Board of Komfo Anokye Teaching Hospital (reference number: KATH-IRB/AP/009A/20).

After giving patients written and verbal information prior to their inclusion in the trial, informed consent was acquired from each study participant. The study protocol was performed with the approval of the Institutional Review Board Komfo Anokye Teaching Hospital where the participant had consented to be part of this study.

Conflicts of Interest

The authors state that they do not have any conflicting interests.

Authors’ Contributions

TB, SS, MA, and AB contributed to the study design and conception, and ID, LB, JY, AB, ES, AD, AA, ST, and RB participated in the data collection. LB, SS, ES, TB, EA, OY, and AB, participated in data analyses and drafted the manuscript. The authors read and endorsed the final manuscript.

Acknowledgments

The authors are grateful to the staff of the Orthopaedic Units of the Komfo Anokye Teaching Hospital and Korle-Bu Teaching Hospital and all who actively participated in the study.

References

J. S. Smolen, R. Landewé, F. C. Breedveld et al., “EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 964–975, 2010.
View at: Publisher Site | Google Scholar
A. Young and G. Koduri, “Extra-articular manifestations and complications of rheumatoid arthritis,” Best Practice and Research: Clinical Rheumatology, vol. 21, no. 5, pp. 907–927, 2007.
View at: Publisher Site | Google Scholar
S. Bas, T. V. Perneger, M. Seitz, J. M. Tiercy, P. Roux-Lombard, and P. A. Guerne, “Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors,” Rheumatology, vol. 41, no. 7, pp. 809–814, 2002.
View at: Publisher Site | Google Scholar
J. S. Smolen, R. B. M. Landewé, S. A. Bergstra et al., “EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update,” Annals of the Rheumatic Diseases, vol. 82, no. 1, pp. 3–18, 2023.
View at: Publisher Site | Google Scholar
S. Ndongo, F. K. Lekpa, M. M. Ka, N. Ndiaye, and T. M. Diop, “Presentation and severity of rheumatoid arthritis at diagnosis in Senegal,” Rheumatology, vol. 48, no. 9, pp. 1111–1113, 2009.
View at: Publisher Site | Google Scholar
B. Ochola, J. Nankabirwa, W. Buwembo, M. Kaddumukasa, and H. Mayanja-Kizza, “The clinical presentation and factors associated with disease severity of rheumatoid arthritis in Uganda: a cross-sectional study,” Open Access Rheumatology: Research and Reviews, vol. 14, pp. 75–86, 2022.
View at: Publisher Site | Google Scholar
A. A. Kalla and M. Tikly, “Rheumatoid arthritis in the developing world,” Best Practice and Research: Clinical Rheumatology, vol. 17, no. 5, pp. 863–875, 2003.
View at: Publisher Site | Google Scholar
K. Chang, S. M. Yang, S. H. Kim, K. H. Han, S. J. Park, and J. I. Shin, “Smoking and rheumatoid arthritis,” International Journal of Molecular Sciences, vol. 15, no. 12, pp. 22279–22295, 2014.
View at: Publisher Site | Google Scholar
S. Viatte and A. Barton, “Genetics of rheumatoid arthritis susceptibility, severity, and treatment response,” Seminars in Immunopathology, vol. 39, no. 4, pp. 395–408, 2017.
View at: Publisher Site | Google Scholar
J. Kay and K. S. Upchurch, “ACR/EULAR 2010 rheumatoid arthritis classification criteria,” Rheumatology, vol. 51, Supplement 6, pp. vi5–vi9, 2012.
View at: Publisher Site | Google Scholar
J. Fransen and P. L. C. M. Van Riel, “The disease activity score and the EULAR response criteria,” Clinical and Experimental Rheumatology, vol. 23, no. 5, p. S93, 2005.
View at: Google Scholar
WHO, Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity (No. WHO/NMH/NHD/MNM/11.1), World Health Organization, 2011.
S. Hewlett, J. Kirwan, C. Bode et al., “The revised Bristol rheumatoid arthritis fatigue measures and the rheumatoid arthritis impact of disease scale: validation in six countries,” Rheumatology, vol. 57, no. 2, pp. 300–308, 2018.
View at: Publisher Site | Google Scholar
M. L. L. Prevoo, M. A. Van’T Hof, H. H. Kuper, M. A. Van Leeuwen, L. B. A. Van De Putte, and P. L. C. M. Van Riel, “Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis & Rheumatism, vol. 38, no. 1, pp. 44–48, 1995.
View at: Publisher Site | Google Scholar
Y. Lee, J. Cui, B. Lu et al., “Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study,” Arthritis Research and Therapy, vol. 13, no. 3, p. R83, 2011.
View at: Publisher Site | Google Scholar
J. Nilsson, M. L. E. Andersson, I. Hafström et al., “Influence of age and sex on disease course and treatment in rheumatoid arthritis,” Open Access Rheumatology: Research and Reviews, vol. 13, pp. 123–138, 2021.
View at: Publisher Site | Google Scholar
J. B. Reese, T. J. Somers, F. J. Keefe, A. Mosley-Williams, and M. A. Lumley, “Pain and functioning of rheumatoid arthritis patients based on marital status: is a distressed marriage preferable to no marriage?” The Journal of Pain, vol. 11, no. 10, pp. 958–964, 2010.
View at: Publisher Site | Google Scholar
M. M. Ward and J. Paul Leigh, “Marital status and the progression of functional disability in patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 36, no. 5, pp. 581–588, 1993.
View at: Publisher Site | Google Scholar
M. Singwe-Ngandeu, J. Meli, H. Ntsiba et al., “Rheumatic diseases in patients attending a clinic at a referral hospital in Yaounde, Cameroon,” East African Medical Journal, vol. 84, no. 9, pp. 404–409, 2007.
View at: Google Scholar
R. Seror, J. Henry, G. Gusto, H. J. Aubin, M. C. Boutron-Ruault, and X. Mariette, “Passive smoking in childhood increases the risk of developing rheumatoid arthritis,” Rheumatology, vol. 58, no. 7, pp. 1154–1162, 2019.
View at: Publisher Site | Google Scholar
Y. Ishikawa and C. Terao, “The impact of cigarette smoking on risk of rheumatoid arthritis: a narrative review,” Cells, vol. 9, no. 2, 2020.
View at: Publisher Site | Google Scholar
H. Masuda, T. Miyazaki, K. Shimada et al., “Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis,” Journal of Cardiology, vol. 64, no. 5, pp. 366–370, 2014.
View at: Publisher Site | Google Scholar
A. Alshevskaya, J. Lopatnikova, J. Zhukova et al., “The influence of severity and disease duration on TNF receptors’ redistribution in asthma and rheumatoid arthritis,” Cells, vol. 12, no. 1, p. 5, 2023.
View at: Publisher Site | Google Scholar
H. Khalkhali, M. Akhlagi, and S. Davar, “Determining the disease severity in patients with rheumatoid arthritis and its related factors using generalized estimator equations model,” Journal of Isfahan Medical School, vol. 38, no. 592, pp. 701–706, 2020.
View at: Publisher Site | Google Scholar
S. S. Zhao, E. Nikiphorou, A. Young, and P. D. W. Kiely, “Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study,” Rheumatology International, vol. 42, no. 4, pp. 621–629, 2022.
View at: Publisher Site | Google Scholar
T. Kanazawa, J. Nishino, S. Tohma, and S. Tanaka, “Analysis of the affected joints in rheumatoid arthritis patients in a large Japanese cohort,” Modern Rheumatology, vol. 23, no. 1, pp. 44–49, 2013.
View at: Publisher Site | Google Scholar
V. Skakic and C. Skakic, “AB1022 involvement of wrist extensor tendons and joints in rheumatoid arthritis assessed by ultrasonography,” Annals of the Rheumatic Diseases, vol. 73, Supplement 2, pp. 1138.2–111138, 2014.
View at: Publisher Site | Google Scholar
R. M. Fleischmann, D. Heijde, P. V. Gardiner, A. Szumski, L. Marshall, and E. Bananis, “DAS28-CRP and DAS28-ESR cut-offs for high disease activity in rheumatoid arthritis are not interchangeable,” RMD Open, vol. 3, no. 1, article e000382, 2017.
View at: Publisher Site | Google Scholar
E. Lindqvist, K. Eberhardt, K. Bendtzen, D. Heinegård, and T. Saxne, “Prognostic laboratory markers of joint damage in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 64, Supplement 3, pp. 196–201, 2005.
View at: Publisher Site | Google Scholar
S. K. Lane and J. W. Gravel, “Clinical utility of common serum rheumatologic tests,” American Family Physician, vol. 65, no. 6, pp. 1073–1081, 2002.
View at: Google Scholar

Copyright

Copyright © 2024 Tonnies Abeku Buckman et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

330

Downloads

218

Citations